Back to Utah

HB0599 • 2026

Social Services Funding Amendments

Social Services Funding Amendments

Enacted

This bill passed the Legislature and reached final enactment based on the latest official action.

Sponsor
Rep. Ward, Raymond P.
Last action
2026-03-25
Official status
Governor Signed
Effective date
Not listed

Plain English Breakdown

Using official source text because the generated explanation was unavailable or could not be confirmed against the official bill text.

Social Services Funding Amendments

This bill addresses social services funding.

What This Bill Does

  • This bill addresses social services funding.

Limits and Unknowns

  • This entry is temporarily using official source text because the generated explanation could not be confirmed against the official bill text during the last sync.

Bill History

  1. 2026-03-25 Lieutenant Governor's office for filing

    Governor Signed

  2. 2026-03-11 Clerk of the House

    House/ received enrolled bill from Printing

  3. 2026-03-11 Executive Branch - Governor

    House/ to Governor

  4. 2026-03-10 Clerk of the House

    Enrolled Bill Returned to House or Senate

  5. 2026-03-10 Clerk of the House

    House/ enrolled bill to Printing

  6. 2026-03-06 Legislative Research and General Counsel / Enrolling

    Bill Received from House for Enrolling

  7. 2026-03-06 Legislative Research and General Counsel / Enrolling

    Draft of Enrolled Bill Prepared

  8. 2026-03-05 House Speaker

    House/ received from Senate

  9. 2026-03-05 Legislative Research and General Counsel / Enrolling

    House/ signed by Speaker/ sent for enrolling

  10. 2026-03-04 Released

    LFA/ fiscal note publicly available for HB0599S03

  11. 2026-03-04 Senate Government Operations and Political Subdivisions Committee

    Senate Comm - Favorable Recommendation

  12. 2026-03-04 Senate 2nd Reading Calendar

    Senate/ 2nd & 3rd readings/ suspension

  13. 2026-03-04 Senate Rules Committee

    Senate/ 2nd Reading Calendar to Rules

  14. 2026-03-04 Senate 2nd Reading Calendar

    Senate/ Rules to 2nd Reading Calendar

  15. 2026-03-04 Senate Government Operations and Political Subdivisions Committee

    Senate/ committee report favorable

  16. 2026-03-04 Senate President

    Senate/ passed 2nd & 3rd readings/ suspension

  17. 2026-03-04 Senate 2nd Reading Calendar

    Senate/ placed on 2nd Reading Calendar

  18. 2026-03-04 House Speaker

    Senate/ signed by President/ returned to House

  19. 2026-03-04 House Speaker

    Senate/ to House

  20. 2026-03-03 House 3rd Reading Calendar for House bills

    House/ 3rd reading

  21. 2026-03-03 Senate Secretary

    House/ passed 3rd reading

  22. 2026-03-03 House 3rd Reading Calendar for House bills

    House/ substituted

  23. 2026-03-03 Senate Secretary

    House/ to Senate

  24. 2026-03-03 Legislative Fiscal Analyst

    LFA/ bill assigned to staff for fiscal analysis for HB0599S02

  25. 2026-03-03 Legislative Fiscal Analyst

    LFA/ bill assigned to staff for fiscal analysis for HB0599S03

  26. 2026-03-03 Legislative Fiscal Agency

    LFA/ bill sent to agencies for fiscal input for HB0599S02

  27. 2026-03-03 Legislative Fiscal Agency

    LFA/ bill sent to agencies for fiscal input for HB0599S03

  28. 2026-03-03 Released

    LFA/ fiscal note publicly available for HB0599S01

  29. 2026-03-03 Released

    LFA/ fiscal note publicly available for HB0599S02

  30. 2026-03-03 Released

    LFA/ fiscal note publicly available for HB0599S03

  31. 2026-03-03 Version Sponsor

    LFA/ fiscal note sent to sponsor for HB0599S01

  32. 2026-03-03 Version Sponsor

    LFA/ fiscal note sent to sponsor for HB0599S02

  33. 2026-03-03 Version Sponsor

    LFA/ fiscal note sent to sponsor for HB0599S03

  34. 2026-03-03 Version Sponsor

    LFA/ fiscal note sent to sponsor for HB0599S03

  35. 2026-03-03 Senate Rules Committee

    Senate/ 1st reading (Introduced)

  36. 2026-03-03 Waiting for Introduction in the Senate

    Senate/ received from House

  37. 2026-03-03 Senate Government Operations and Political Subdivisions Committee

    Senate/ to standing committee

  38. 2026-03-02 House Rules Committee

    House Comm - Favorable Recommendation

  39. 2026-03-02 House Rules Committee

    House Comm - Substitute Recommendation

  40. 2026-03-02 House 3rd Reading Calendar for House bills

    House/ 2nd reading

  41. 2026-03-02 House Rules Committee

    House/ comm rpt/ substituted

  42. 2026-03-02 House Rules Committee

    House/ received fiscal note from Fiscal Analyst

  43. 2026-03-01 Legislative Fiscal Analyst

    LFA/ bill assigned to staff for fiscal analysis for HB0599S01

  44. 2026-03-01 Legislative Fiscal Agency

    LFA/ bill sent to agencies for fiscal input for HB0599S01

  45. 2026-02-28 Released

    LFA/ fiscal note publicly available for HB0599

  46. 2026-02-28 Version Sponsor

    LFA/ fiscal note sent to sponsor for HB0599

  47. 2026-02-25 Legislative Research and General Counsel

    Bill Numbered but not Distributed

  48. 2026-02-25 House Rules Committee

    House/ 1st reading (Introduced)

  49. 2026-02-25 Clerk of the House

    House/ received bill from Legislative Research

  50. 2026-02-25 Legislative Fiscal Analyst

    LFA/ bill assigned to staff for fiscal analysis for HB0599

  51. 2026-02-25 Legislative Fiscal Agency

    LFA/ bill sent to agencies for fiscal input for HB0599

  52. 2026-02-25 Legislative Research and General Counsel

    Numbered Bill Publicly Distributed

Official Summary Text

This bill addresses social services funding.

Current Bill Text

Read the full stored bill text
60
26B-1-315
26B-1-315
26B-3-105
26B-3-902
59-14-807
0
Social Services Funding Amendments
2026 GENERAL SESSION
STATE OF UTAH
Chief Sponsor: Raymond P. Ward
Senate Sponsor: Keven J. Stratton
LONG TITLE
General Description:
This bill addresses social services funding.
Highlighted Provisions:
This bill:
provides that interest earned on money in the Medicaid ACA Fund shall be deposited into
the General Fund;
requires immunosuppressive drugs to be added to the Medicaid preferred drug list;
requires the Department of Health and Human Services (department) to:
transition the state's Children's Health Insurance Program from a separate program, to
providing benefits under the state's Medicaid program; and
after the transition, to the extent possible, provide dental services to individuals
covered by the Children's Health Insurance Program through the University of Utah
School of Dentistry;
requires certain funds to be distributed from the Electronic Cigarette Substance and
Nicotine Product Proceeds Restricted Account for substance use treatment and
prevention services; and
makes technical and conforming changes.
Money Appropriated in this Bill:
This bill appropriates
($759,700)
in operating and capital budgets for fiscal year 2026, all
of which is from the General Fund.
This bill appropriates
($759,700)
in operating and capital budgets for fiscal year 2027, all of
which is from the General Fund.
Other Special Clauses:
This bill provides a special effective date.
Utah Code Sections Affected:
AMENDS:
26B-1-315
Effective
05/06/26
Superseded
07/01/26
, as last amended by Laws of Utah
2025, Chapter 135
26B-1-315
Effective
07/01/26
Repealed
07/01/34
, as last amended by Laws of Utah
2025, Chapter 285
26B-3-105
Effective
05/06/26
, as last amended by Laws of Utah 2025, Chapter 135
26B-3-902
Effective
05/06/26
, as renumbered and amended by Laws of Utah 2023,
Chapter 306
59-14-807
Effective
05/06/26
Partially Repealed
07/01/30
, as last amended by Laws
of Utah 2025, Chapters 173, 366
Be it enacted by the Legislature of the state of Utah:
Section 1. Section
26B-1-315
is amended to read:
26B-1-315
Effective
05/06/26
Superseded
07/01/26
. Medicaid ACA Fund.
(1)
There is created an expendable special revenue fund known as the "Medicaid ACA
Fund."
(2)
The fund consists of:
(a)
assessments collected under Chapter 3, Part 5, Inpatient Hospital Assessment;
(b)
intergovernmental transfers under Section
26B-3-508
;
(c)
savings attributable to the health coverage improvement program, as defined in
Section
26B-3-501
, as determined by the department;
(d)
savings attributable to the enhancement waiver program, as defined in Section
26B-3-501
, as determined by the department;
(e)
savings attributable to the Medicaid waiver expansion, as defined in Section
26B-3-501
, as determined by the department;
(f)
revenues collected from the sales tax described in Subsection
59-12-103(11)
;
(g)
gifts, grants, donations, or any other conveyance of money that may be made to the
fund from private sources;
and
(h)
interest earned on money in the fund; and
(i)
(h)
additional amounts as appropriated by the Legislature.
(3)
(a)
The fund shall earn interest.
(b)
All interest earned on fund money
in a fiscal year beginning on or after July 1, 2025,

shall be deposited into the
fund
General Fund
.
(4)
(a)
A state agency administering the provisions of Chapter 3, Part 5, Inpatient
Hospital Assessment, may use money from the fund to pay the costs, not otherwise
paid for with federal funds or other revenue sources, of:
(i)
the health coverage improvement program as defined in Section
26B-3-501
;
(ii)
the enhancement waiver program as defined in Section
26B-3-501
;
(iii)
a Medicaid waiver expansion as defined in Section
26B-3-501
; and
(iv)
the outpatient upper payment limit supplemental payments under Section
26B-3-511
.
(b)
A state agency administering the provisions of Chapter 3, Part 5, Inpatient Hospital
Assessment, may not use:
(i)
funds described in Subsection
(2)(b)
to pay the cost of private outpatient upper
payment limit supplemental payments; or
(ii)
money in the fund for any purpose not described in Subsection
(4)(a)
.
Section 2. Section
26B-1-315
is amended to read:
26B-1-315
Effective
07/01/26
Repealed
07/01/34
. Medicaid ACA Fund.
(1)
There is created an expendable special revenue fund known as the "Medicaid ACA
Fund."
(2)
The fund consists of:
(a)
assessments collected under Chapter 3, Part 5, Inpatient Hospital Assessment;
(b)
intergovernmental transfers under Section
26B-3-508
;
(c)
savings attributable to the health coverage improvement program, as defined in
Section
26B-3-501
, as determined by the department;
(d)
savings attributable to the enhancement waiver program, as defined in Section
26B-3-501
, as determined by the department;
(e)
savings attributable to the Medicaid waiver expansion, as defined in Section
26B-3-501
, as determined by the department;
(f)
revenues collected from the sales tax described in Subsection
59-12-103(6)
;
(g)
gifts, grants, donations, or any other conveyance of money that may be made to the
fund from private sources;
and
(h)
interest earned on money in the fund; and
(i)
(h)
additional amounts as appropriated by the Legislature.
(3)
(a)
The fund shall earn interest.
(b)
All interest earned on fund money
in a fiscal year beginning on or after July 1, 2025
,

shall be deposited into the
fund
General Fund
.
(4)
(a)
A state agency administering the provisions of Chapter 3, Part 5, Inpatient
Hospital Assessment, may use money from the fund to pay the costs, not otherwise
paid for with federal funds or other revenue sources, of:
(i)
the health coverage improvement program as defined in Section
26B-3-501
;
(ii)
the enhancement waiver program as defined in Section
26B-3-501
;
(iii)
a Medicaid waiver expansion as defined in Section
26B-3-501
; and
(iv)
the outpatient upper payment limit supplemental payments under Section
26B-3-511
.
(b)
A state agency administering the provisions of Chapter 3, Part 5, Inpatient Hospital
Assessment, may not use:
(i)
funds described in Subsection
(2)(b)
to pay the cost of private outpatient upper
payment limit supplemental payments; or
(ii)
money in the fund for any purpose not described in Subsection
(4)(a)
.
Section 3. Section
26B-3-105
is amended to read:
26B-3-105
Effective
05/06/26
. Medicaid drug program -- Preferred drug list.
(1)
As used in this section:
(a)
"Immunosuppressive drug" means a drug that:
(i)
is used in immunosuppressive therapy to inhibit or prevent activity of the immune
system to aid the body in preventing the rejection of transplanted organs and
tissue; and
(ii)
does not include drugs used for the treatment of autoimmune disease or diseases
that are most likely of autoimmune origin.
(b)
"Psychotropic drug" means the following classes of drugs:
(i)
anti-depressant;
(ii)
anti-convulsant/mood stabilizer;
(iii)
anti-anxiety; and
(iv)
attention deficit hyperactivity disorder stimulant.
(c)
"Stabilized" means a health care provider has documented in the patient's medical
chart that a patient has achieved a stable or steadfast medical state within the past 90
days.
(2)
A Medicaid drug program developed by the department under Subsection
26B-3-104(2)(f)
:
(a)
shall, notwithstanding Subsection
26B-3-104(1)(b)
, be based on clinical and
cost-related factors which include medical necessity as determined by a provider in
accordance with administrative rules established by the Drug Utilization Review
Board;
(b)
may include therapeutic categories of drugs that may be exempted from the drug
program;
(c)
notwithstanding Section
58-17b-606
, may include placing some drugs on a preferred
drug list:
(i)
to the extent determined appropriate by the department; and
(ii)
in the manner described in Subsection
(4)
for atypical anti-psychotic drugs;
(d)
notwithstanding the requirements of Sections
26B-3-302
through
26B-3-309

regarding the Drug Utilization Review Board, and except as provided in Subsection
(4)
, shall immediately implement the prior authorization requirements for a
nonpreferred drug that is in the same therapeutic class as a drug that is:
(i)
on the preferred drug list on the date
that
this act
takes effect; or
(ii)
added to the preferred drug list after

this act

takes effect; and
(e)
except as prohibited by Subsections
58-17b-606(4)
and
(5)
, shall establish the prior
authorization requirements which shall permit a health care provider or the health
care provider's agent to obtain a prior authorization override of the preferred drug list
through the department's pharmacy prior authorization review process, and which
shall:
(i)
provide either telephone or fax approval or denial of the request within 24 hours of
the receipt of a request that is submitted during normal business hours of Monday
through Friday from 8 a.m. to 5 p.m.;
(ii)
provide for the dispensing of a limited supply of a requested drug as determined
appropriate by the department in an emergency situation, if the request for an
override is received outside of the department's normal business hours; and
(iii)
require the health care provider to provide the department with documentation of
the medical need for the preferred drug list override in accordance with criteria
established by the department in consultation with the Pharmacy and Therapeutics
Committee.
(3)
(a)
(i)
A
Except as provided in Subsection
(3)(a)(ii)
, a
preferred drug list
developed under the provisions of this section may not include an
immunosuppressive drug.
(ii)
Beginning on March 1, 2027, the department shall include immunosuppressive
drugs on the preferred drug list.
(i)
(b)
The state Medicaid program shall reimburse for a prescription for an
immunosuppressive drug as written by the health care provider for a patient who has
undergone an organ transplant.
(ii)
(c)
For purposes of Subsection
58-17b-606(4)
, and with respect to patients who
have undergone an organ transplant, the prescription for a particular
immunosuppressive drug as written by a health care provider meets the criteria of
demonstrating to the department a medical necessity for dispensing the prescribed
immunosuppressive drug.
(iii)
(d)
Notwithstanding the requirements of Sections
26B-3-302
through
26B-3-309

regarding the Drug Utilization Review Board, the state Medicaid drug program may
not require the use of step therapy for immunosuppressive drugs without the written
or oral consent of the health care provider and the patient.
(4)
(a)
(i)
The department shall include atypical anti-psychotic drugs on the preferred
drug list.
(ii)
The department shall allow a health care provider to override the preferred drug
list for an atypical anti-psychotic drug by writing "dispense as written" on the
prescription for the atypical anti-psychotic drug.
(iii)
A health care provider may not override Section
58-17b-606
by writing
"dispense as written" on a prescription.
(b)
The department, and a Medicaid accountable care organization that is responsible for
providing behavioral health, shall

establish a system to:
(i)
track health care provider prescribing patterns for atypical anti-psychotic drugs;
(ii)
educate health care providers who are not complying with the preferred drug list;
and
(iii)
implement peer to peer education for health care providers whose prescribing
practices continue to not comply with the preferred drug list.
(5)
For enrollees that begin a psychotropic drug treatment on or after July 1, 2025, the
department shall pay for a psychotropic drug that is not on the preferred drug list if the
department, based on patient claims history or health care provider attestation, has
evidence of:
(a)
an enrollee's trial and failure of a psychotropic drug on the preferred drug list that is
equivalent or similar to the drug that is not on the preferred drug list in the last 365
days; or
(b)
the enrollee being stabilized on the psychotropic drug that is not on the preferred
drug list at the time of enrollment.
Section 4. Section
26B-3-902
is amended to read:
26B-3-902
Effective
05/06/26
. Creation and administration of the Utah
Children's Health Insurance Program.
(1)
There is created the Utah Children's Health Insurance Program to be administered by
the department in accordance with the provisions of:
(a)
this part; and
(b)
the State Children's Health Insurance Program, 42 U.S.C. Sec. 1397aa et seq.
(2)
The department shall:
(a)
prepare and submit the state's children's health insurance plan before May 1, 1998,
and any amendments to the United States Department of Health and Human Services
in accordance with 42 U.S.C. Sec. 1397ff; and
(b)
make rules in accordance with
Title 63G, Chapter 3, Utah Administrative
Rulemaking Act
, regarding:
(i)
eligibility requirements consistent with Section
26B-3-108
;
(ii)
program benefits;
(iii)
the level of coverage for each program benefit;
(iv)
cost-sharing requirements for members, which may not:
(A)
exceed the guidelines set forth in 42 U.S.C. Sec. 1397ee; or
(B)
impose deductible, copayment, or coinsurance requirements on a member for
well-child, well-baby, and immunizations;
(v)
the administration of the program; and
(vi)
a requirement that:
(A)
members in the program shall participate in the electronic exchange of clinical
health records established in accordance with Section
26B-8-411
unless the
member opts out of participation;
(B)
prior to enrollment in the electronic exchange of clinical health records the
member shall receive notice of the enrollment in the electronic exchange of
clinical health records and the right to opt out of participation at any time; and
(C)
beginning July 1, 2012, when the program sends enrollment or renewal
information to the member and when the member logs onto the program's
website, the member shall receive notice of the right to opt out of the electronic
exchange of clinical health records.
(3)
(a)
Before July 1, 2026, the department shall apply for a state plan amendment to
transition the state's Children's Health Insurance Program from a separate program
under 42 U.S.C. Sec. 1397aa(a)(1), to providing benefits under the state's Medicaid
program under 42 U.S.C. Sec. 1397aa(1)(2).
(b)
If the application described in Subsection
(3)(a)
is approved, and the state's
Children's Health Insurance Program transitions as described in Subsection
(3)(a)
, to
the extent possible, dental services for individuals covered by the state's Children's
Health Insurance Program shall be provided through the University of Utah School of
Dentistry and the University of Utah School of Dentistry's associated statewide
network.
Section 5. Section
59-14-807
is amended to read:
59-14-807
Effective
05/06/26
Partially Repealed
07/01/30
. Electronic
Cigarette Substance and Nicotine Product Proceeds Restricted Account.
(1)
There is created within the General Fund a restricted account known as the "Electronic
Cigarette Substance and Nicotine Product Proceeds Restricted Account."
(2)
The Electronic Cigarette Substance and Nicotine Product Proceeds Restricted Account
consists of:
(a)
revenue collected from the tax imposed by Section
59-14-804
;
(b)
fees and penalties collected under Section
59-14-810
;
(c)
all money received by the attorney general or the Department of Commerce as a
result of any judgment, settlement, or compromise of claims pertaining to alleged
violations of law related to the manufacture, marketing, distribution, or sale of
electronic cigarette products, as defined in Section
76-9-1101
:
(i)
if the total amount of the judgment, settlement, or compromise received by the
state exceeds $1,000,000; and
(ii)
after reimbursement to the attorney general and the Department of Commerce for
expenses related to the matters described in this Subsection
(2)(c)
; and
(d)
amounts appropriated by the Legislature.
(3)
(a)
Subject to Subsections
(3)(b)
and
(c)
, for each fiscal year and subject to
appropriation by the Legislature, the Division of Finance shall distribute from the
Electronic Cigarette Substance and Nicotine Product Proceeds Restricted Account:
(i)
$2,000,000 to the Department of Health and Human Services for enforcement
services aimed at disrupting organizations and networks that provide tobacco
products, electronic cigarette products, nicotine products, or other illegal
controlled substances to minors, which the Department of Health and Human
Services shall allocate to the local health departments using the formula created in
accordance with Section
26A-1-116
;
(ii)
$1,180,000 to the Department of Public Safety for law enforcement officers
aimed at disrupting organizations and networks that provide tobacco products,
electronic cigarette products, nicotine products, and other illegal controlled
substances to minors;
(iii)
$1,000,000 to the Department of Health and Human Services for enforcement
services aimed at disrupting organizations and networks that provide tobacco
products, electronic cigarette products, nicotine products, and other illegal
controlled substances to minors;
(iv)
$3,000,000 to the Department of Health and Human Services for community
partner prevention programs, which the Department of Health and Human
Services shall allocate to the local health departments using the formula created in
accordance with Section
26A-1-116
;
(v)
$1,000,000 to the Department of Health and Human Services for statewide
cessation programs and prevention education;
(vi)
$2,000,000 to the Department of Health and Human Services for alcohol,
tobacco, and other drug prevention, reduction, cessation, and control programs
that promote unified messages and make use of media outlets, including radio,
newspaper, billboards, and television;
and
(vii)
$759,700 to the Department of Health and Human Services for the Office of
Substance Use and Mental Health to provide substance use treatment and
prevention services, including Medicaid matching funds for substance use
treatment services; and
(vii)
(viii)
$5,084,200 to the State Board of Education for school-based prevention
programs.
(b)
If the amount in the Electronic Cigarette Substance and Nicotine Product Proceeds
Restricted Account is insufficient to cover the distributions described in Subsection
(3)(a)
, the Division of Finance shall make the distributions under Subsection
(3)(a)
:
(i)
sequentially in the order of priority the distributions are listed under Subsection
(3)(a)
;
(ii)
in full or, if insufficient funds are available to satisfy the next distribution in the
sequence, in part; and
(iii)
until the available funds in the Electronic Cigarette Substance and Nicotine
Product Proceeds Restricted Account are exhausted.
(c)
For each fiscal year and subject to appropriation by the Legislature, the Division of
Finance shall distribute from the funds deposited under Section
59-14-810
into the
Electronic Cigarette Substance and Nicotine Product Proceeds Restricted Account:
(i)
to the commission, in an amount equal to the amount necessary to create and
maintain the registry described in Section
59-14-810
;
(ii)
to the Department of Health and Human Services, in an amount necessary for
completing duties described in Section
59-14-810
; and
(iii)
to the Department of Health and Human Services, the remainder to be divided
among the local health departments for inspection and enforcement described in
Sections
26A-1-131
and
59-14-810
.
(4)
(a)
The local health departments shall use the money received in accordance with
Subsection
(3)(a)
for enforcing:
(i)
the regulation provisions described in Section
26B-7-505
;
(ii)
the labeling requirement described in Section
26B-7-505
; and
(iii)
the penalty provisions described in Section
26B-7-518
.
(b)
The Department of Health and Human Services shall use the money received in
accordance with Subsection
(3)(a)(v)
for the Youth Electronic Cigarette, Marijuana,
and Other Drug Prevention Program created in Section
26B-1-428
.
(c)
The local health departments shall use the money received in accordance with
Subsection
(3)(a)(iv)
to issue grants under the Electronic Cigarette, Marijuana, and
Other Drug Prevention Grant Program created in Section
26A-1-129
.
(d)
The State Board of Education shall use the money received in accordance with
Subsection
(3)(a)(vii)
to distribute to local education agencies to pay for:
(i)
(A)
stipends for positive behaviors specialists as described in Subsection
53G-10-407(4)(a)(i)
;
(B)
the cost of administering the positive behaviors plan as described in
Subsection
53G-10-407(4)(a)(ii)
; and
(C)
the cost of implementing an Underage Drinking and Substance Abuse
Prevention Program in grade 4 or 5, as described in Subsection
53G-10-406(3)(b)
; or
(ii)
a comprehensive prevention plan, as that term is defined in Section
53F-2-525
.
(5)
(a)
The fund shall earn interest.
(b)
All interest earned on fund money shall be deposited into the fund.
(6)
Subject to legislative appropriations, funds remaining in the Electronic Cigarette
Substance and Nicotine Product Proceeds Restricted Account after the distribution
described in Subsection
(3)
may only be used for:
(a)
funding commission personnel to enforce compliance with the tax collection
requirements of this part; and
(b)
programs and activities related to the prevention and cessation of electronic cigarette,
nicotine products, marijuana, and other drug use.
Section 6.
FY 2026 Appropriations.
The following sums of money are appropriated for the fiscal year beginning July 1,
2025, and ending June 30, 2026. These are additions to amounts previously appropriated for
fiscal year 2026.
Subsection 6(a).
Operating and Capital Budgets
Under the terms and conditions of Title 63J, Chapter 1, Budgetary Procedures Act, the
Legislature appropriates the following sums of money from the funds or accounts indicated for
the use and support of the government of the state of Utah.
SOCIAL SERVICES
DEPARTMENT OF HEALTH AND HUMAN SERVICES
ITEM 1
Department of Health and Human Services - Integrated Health Care Services
From General Fund, One-time
(759,700)
Non-Medicaid Behavioral Health Treatment and
Crisis Response
(759,700)
Section 7.
FY 2027 Appropriations.
The following sums of money are appropriated for the fiscal year beginning July 1,
2026, and ending June 30, 2027. These are additions to amounts previously appropriated for
fiscal year 2027.
Subsection 7(a).
Operating and Capital Budgets
Under the terms and conditions of Title 63J, Chapter 1, Budgetary Procedures Act, the
Legislature appropriates the following sums of money from the funds or accounts indicated for
the use and support of the government of the state of Utah.
SOCIAL SERVICES
DEPARTMENT OF HEALTH AND HUMAN SERVICES
ITEM 2
Department of Health and Human Services - Integrated Health Care Services
From General Fund
(759,700)
Non-Medicaid Behavioral Health Treatment and
Crisis Response
(759,700)
Section 8.
Effective Date.
(1)
Except as provided in Subsection (2), this bill takes effect
May 6, 2026
.
(2)
The actions affecting Section 26B-1-315
Effective
07/01/26
Repealed
07/01/34
take
effect on
July 1, 2026
.
3-10-26 9:35 AM